Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Structure-based computational approaches for small-molecule modulation of protein-protein interactions
David Xu1, Bo Wang, Samy O Meroueh
1Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, 410 W. 10th Street, Indianapolis, IN, 46202, USA.
Rational drug design uses protein 3D structures to create small molecules that inhibit protein-protein interactions (PPIs). Computational methods like molecular docking identify potential drug candidates for PPIs.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Protein-protein interactions (PPIs) are crucial in cellular processes.
- Modulating PPIs with small molecules offers therapeutic potential.
- 3D protein structures enable rational drug design targeting PPIs.
Purpose of the Study:
- To evaluate computational methods for identifying binding pockets on protein interfaces.
- To assess the efficacy of molecular docking in predicting inhibitor binding poses.
- To highlight the strengths and limitations of computational approaches for designing PPI inhibitors.
Main Methods:
- Utilized protein 3D structures for rational drug design.
- Employed pocket-finding programs (e.g., SiteMap, fpocket, FTSite) to identify potential binding sites.
- Performed molecular docking (e.g., AutoDock Vina) to screen chemical libraries and predict binding poses of known inhibitors.
Main Results:
- Successfully identified binding pockets on protein interfaces suitable for small molecule binding.
- Molecular docking reproduced known inhibitor binding poses for selected PPI targets.
- Demonstrated the utility of computational screening for prioritizing compounds for experimental validation.
Conclusions:
- Computational methods are valuable tools for the rational design of PPI inhibitors.
- Pocket identification and molecular docking show promise in accelerating drug discovery for PPIs.
- Understanding the limitations of these methods is crucial for successful application in drug design.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Protein-protein Interfaces
Protein-Protein Interfaces
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...